HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.

Abstract
Some solid tumors have reduced posttranscriptional RNA editing by adenosine deaminase acting on RNA (ADAR) enzymes, but the functional significance of this alteration has been unclear. Here, we found the primary RNA-editing enzyme ADAR1 is frequently reduced in metastatic melanomas. In situ analysis of melanoma samples using progression tissue microarrays indicated a substantial downregulation of ADAR1 during the metastatic transition. Further, ADAR1 knockdown altered cell morphology, promoted in vitro proliferation, and markedly enhanced the tumorigenicity in vivo. A comparative whole genome expression microarray analysis revealed that ADAR1 controls the expression of more than 100 microRNAs (miRNAs) that regulate many genes associated with the observed phenotypes. Importantly, we discovered that ADAR1 fundamentally regulates miRNA processing in an RNA binding–dependent, yet RNA editing–independent manner by regulating Dicer expression at the translational level via let-7. In addition, ADAR1 formed a complex with DGCR8 that was mutually exclusive with the DGCR8-Drosha complex that processes pri-miRNAs in the nucleus. We found that cancer cells silence ADAR1 by overexpressing miR-17 and miR-432, which both directly target the ADAR1 transcript. We further demonstrated that the genes encoding miR-17 and miR-432 are frequently amplified in melanoma and that aberrant hypomethylation of the imprinted DLK1-DIO3 region in chromosome 14 can also drive miR-432 overexpression.
AuthorsYael Nemlich, Eyal Greenberg, Rona Ortenberg, Michal J Besser, Iris Barshack, Jasmine Jacob-Hirsch, Elad Jacoby, Eran Eyal, Ludmila Rivkin, Victor G Prieto, Nitin Chakravarti, Lyn M Duncan, David M Kallenberg, Eitan Galun, Dorothy C Bennett, Ninette Amariglio, Menashe Bar-Eli, Jacob Schachter, Gideon Rechavi, Gal Markel
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 123 Issue 6 Pg. 2703-18 (Jun 2013) ISSN: 1558-8238 [Electronic] United States
PMID23728176 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • DGCR8 protein, human
  • MIRN17 microRNA, human
  • MIRN432 microRNA, human
  • MicroRNAs
  • Pregnancy Proteins
  • Proteins
  • RNA-Binding Proteins
  • RTL1 protein, human
  • DICER1 protein, human
  • DROSHA protein, human
  • Ribonuclease III
  • ADARB1 protein, human
  • Adenosine Deaminase
  • DEAD-box RNA Helicases
Topics
  • Adenosine Deaminase (genetics, metabolism)
  • Animals
  • Binding Sites
  • Cell Line, Tumor
  • Cell Proliferation
  • DEAD-box RNA Helicases (genetics, metabolism)
  • DNA Methylation
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • Melanoma (metabolism, secondary)
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • MicroRNAs (genetics, metabolism)
  • Neoplasm Transplantation
  • Pregnancy Proteins (genetics)
  • Proteins (genetics, metabolism)
  • RNA Editing
  • RNA Interference
  • RNA-Binding Proteins
  • Ribonuclease III (genetics, metabolism)
  • Transcriptome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: